Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and order wins, here’s a quick look at which stocks will be in focus in today's trade:
UltraTech Cement, Dr Reddy's Laboratories, Hindustan Petroleum Corporation, Indus Towers, United Spirits, Adani Energy Solutions, Adani Green Energy, Amber Enterprises India, Capri Global Capital, Cyient, Greaves Cotton, Indian Energy Exchange, KFin Technologies, Mankind Pharma, Mphasis, Nippon Life India Asset Management, Senores Pharmaceuticals, Sona BLW Precision Forgings, Spandana Sphoorty Financial, Suryoday Small Finance Bank, Syngene International, Tejas Networks, Thyrocare Technologies, Ujjivan Small Finance Bank, V2 Retail, and Zee Entertainment Enterprises will announce their quarterly earnings on January 23.
Hindustan Unilever Q3 (Standalone YoY)
Profit jumps 19.1% to Rs 3,001 crore Vs Rs 2,519 crore
Revenue grows 1.4% to Rs 15,408 crore Vs Rs 15,188 crore
EBITDA increases 0.8% to Rs 3,570 crore Vs Rs 3,540 crore
Margin falls 10 bps to 23.2% Vs 23.3%
Exceptional gain of Rs 509 crore Vs loss of Rs 30 crore
Board approves demerger of ice cream business, Kwality Wall's (India)
Board approves acquisition of palm undertaking of Vishwatej Oil Industries, as a part of HUL’s palm localisation strategy
Board approves acquisition of 90.5% stake in Uprising Science for cash consideration of Rs 2,670 crore at a pre-money enterprise valuation of Rs 2,955 crore
Bharat Petroleum Corporation Q23 (Standalone QoQ)
Profit zooms 93.9% to Rs 4,649.2 crore Vs Rs 2,397.2 crore
Revenue grows 10.1% to Rs 1,13,135.8 crore Vs Rs 1,02,756.1 crore
EBITDA jumps 68% to Rs 7,580.4 crore Vs Rs 4,512.1 crore
Margin expands to 6.7% Vs 4.4%
Board approves formation of joint venture company with Praj Industries for setting up compressed bio gas (CBG) plants across India
Board approves submission of development plan to Indonesian Regulator for development of Nunukan block for oil and gas reserves
Persistent Systems Q3 (Consolidated QoQ)
Profit grows 14.8% to Rs 373 crore Vs Rs 325 crore
Revenue increases 5.7% to Rs 3,062.3 crore Vs 2,897.2 crore
Pidilite Industries Q3 (Consolidated YoY)
Profit rises 9% to Rs 557 crore Vs Rs 510.9 crore
Revenue increases 7.6% to Rs 3,368.9 crore Vs Rs 3,130 crore
Gravita India Q3 (Consolidated YoY)
Profit soars 29.3% to Rs 78 crore Vs Rs 60.3 crore
Revenue zooms 31.5% to Rs 996.4 crore Vs Rs 757.8 crore
Laxmi Organic Industries Q3 (Consolidated YoY)
Profit increases 7.8% to Rs 29.3 crore Vs Rs 27.2 crore
Revenue jumps 13.3% to Rs 786.3 crore Vs Rs 694.3 crore
Cigniti Technologies Q3 (Consolidated YoY)
Profit soars 32.3% to Rs 63.6 crore Vs Rs 48.04 crore
Revenue grows 10.3% to Rs 516.4 crore Vs Rs 468 crore
Go Digit General Insurance Q3 (YoY)
Gross written premium grows 10.3% to Rs 2,677 crore Vs Rs 2,428 crore
Profit surges 176.7% to Rs 119 crore Vs Rs 43 crore
Assets under management jumps 27% to Rs 18,939 crore Vs Rs 14,909 crore
Combined ratio drops to 108.1% Vs 110.3%
Stocks To Watch
The US Food and Drug Administration (US FDA) conducted a Post-marketing Adverse Drug Experience (PADE) inspection of the company's subsidiary, Laurus Generics Inc., based in New Jersey, USA, for four days, from January 13 to 21, 2025. The inspection included a comprehensive review of practices and procedures for reporting adverse events related to Laurus Labs' marketed products worldwide.
Paras Defence and Space Technologies
The company has signed a Memorandum of Understanding (MoU) with the Maharashtra government for the proposed Optics Park Project in Navi Mumbai. The Optics Park Project is set to commence in 2028. Upon allocation of land and requisite subsidies by the Maharashtra government, the company plans to invest approximately Rs 12,000 crore in the Optics Park over a period of 10 years.
The Piramal Critical Care division of the company has launched Chlorpromazine Hydrochloride for injection in the US. Chlorpromazine Hydrochloride for injection is used to treat various disorders, including schizophrenia and other psychoses.
The company has signed an agreement to set up a 1.0 MTPA cement grinding unit at Bhushan Power’s premises in Sambalpur. The purchase consideration will be up to Rs 380 crore.
Container freight station (CFS) volumes fell 2.5% YoY to 51,700 TEUs but grew 8.4% MoM. Volumes rebounded in December 2024, reaching the highest levels in the quarter, in line with overall port volumes.
The company has received an export order worth $4.29 million. The order involves the supply, installation, testing, and commissioning of EMI components for a 16.5 MLD WTP to upgrade the drinking water supply system in southern Abidjan, Gueyo, and its surrounding areas in Ivory Coast.
The company has opened its Qualified Institutional Placement (QIP) issue. The floor price has been fixed at Rs 151.09 crore.
The Board will consider raising funds through equity and debt instruments on January 29.
The Income Tax Authority has issued a transfer pricing order for Rs 26.5 crore for Sanofi India for the assessment year 2022-23.
Mainboard Listing on January 23
Stallion India Fluorochemicals
SME Listing on January 23
Landmark Immigration Consultants
Stock Trades Ex-Date For Income Distribution (InvIT)
Property Share Investment Trust
F&O Ban
IndiaMART InterMESH, Punjab National Bank, Aditya Birla Fashion & Retail, Bandhan Bank, Can Fin Homes, Dixon Technologies, L&T Finance, Manappuram Finance, Mahanagar Gas, RBL Bank
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
